Merck Receives Fast-Track Designation for Tepotinib in Non-Sma...
- Written by LATEST ASIANET NEWS RELEASES
- Category: Asia Net
DARMSTADT, Germany, March 27, 2018 /PRNewswire-AsiaNet/ -- Not intended for UK- or US-based media- Japanese Ministry of Health, Labour and Welfare Grants SAKIGAKE designation for tepotinib, Merck's investigational highly selective c-Met receptor tyrosine kinase inhibitor - First......




